1,119 results on '"Paesmans, M."'
Search Results
2. Discriminating value of HR-pQCT for fractures in women with similar FRAX scores: A substudy of the FRISBEE cohort
3. Risk factors for imminent fractures: a substudy of the FRISBEE cohort
4. Regorafenib after failure of gemcitabine and platinum-based chemotherapy for locally advanced/metastatic biliary tumors: REACHIN, a randomized, double-blind, phase II trial
5. What is the validity of self-reported fractures?
6. Retrospective evaluation of the safety of low-level laser therapy/photobiomodulation in patients with head/neck cancer
7. Osteoporosis treatment gap in a prospective cohort of volunteer women
8. Cancer bronchique : le pronostic en soins intensifs dépendrait surtout de la complication
9. Clinical significance of CD73 in triple-negative breast cancer: multiplex analysis of a phase III clinical trial
10. Predictive factors for cancer-associated thrombosis in a large retrospective single-center study
11. Are concurrent systematic cores needed at the time of targeted biopsy in patients with prior negative prostate biopsies?
12. Score inflammatoire de Glasgow et cancer bronchique : une aide pour hospitaliser aux urgences
13. Difficultés et limites dans la conduite d’une étude translationnelle en oncologie thoracique. Un exemple pratique
14. Implémentation d’un programme de soins oncologiques en consultation multidisciplinaire
15. Empiric vs Preemptive Antifungal Strategy in High-Risk Neutropenic Patients on Fluconazole Prophylaxis: A Randomized Trial of the European Organization for Research and Treatment of Cancer.
16. 64P Baseline characteristics associated with Ki67 drop after neoadjuvant endocrine therapy in patients with HR+/HER2- early breast cancer: A systematic review
17. 115P BrainStorm-NSE: Serum neuron-specific enolase as a biomarker for central nervous system metastases: A prospective cohort study
18. Intravenous iron therapy for anemic cancer patients: a review of recently published clinical studies
19. Controversial issues in early-stage breast cancer: a global collaborative survey, supported by the European Society for Medical Oncology (ESMO)
20. The landscape of medical oncology in Europe by 2020
21. First 200 consecutive transumbilical single-incision laparoscopic TEPs
22. Prophylactic Cranial Irradiation
23. Phase I trial combining temozolomide plus lapatinib for the treatment of brain metastases in patients with HER2-positive metastatic breast cancer: the LAPTEM trial
24. Identification of microRNA-based signatures for response and survival for non-small cell lung cancer treated with cisplatin-vinorelbine A ELCWP prospective study
25. 290P Subtype-specific prognostic value of lobular histology in patients with early-stage breast cancer: A nationwide population-based study
26. Rate and patterns of ICU admission among colorectal cancer patients: a single-center experience
27. Final results and pharmacoeconomic analysis of a trial comparing two neoadjuvant chemotherapy (CT) regimens followed by surgery in patients with resectable non-small cell lung cancer (NSCLC): A phase II randomised study by the European Lung Cancer Working Party
28. Serial FDG–PET/CT for early outcome prediction in patients with metastatic colorectal cancer undergoing chemotherapy
29. Role of the multidisciplinary team in breast cancer management: results from a large international survey involving 39 countries
30. Best Supportive Care or Chemotherapy for Stage IV Non-Small Cell Lung Cancer
31. Tomographie par émission de positons au 18F-FDG et réponse anticancéreuse. Détermination de la réponse à la chimiothérapie de première ligne des cancers bronchiques non à petites cellules avancés : critères métaboliques ou morphologiques ?
32. A general chemotherapy myelotoxicity score to predict febrile neutropenia in hematological malignancies
33. A phase III randomised study comparing concomitant radiochemotherapy as induction versus consolidation treatment in patients with locally advanced unresectable non-small cell lung cancer
34. Single-access laparoscopic primary and incisional prosthetic hernia repair: first 50 patients
35. Non-malignant causes of hypercalcemia in cancer patients: a frequent and neglected occurrence
36. 659MO Avelumab (A) as the basis of neoadjuvant chemotherapy (NAC) regimen in platinum eligible and ineligible patients (pts) with non-metastatic muscle invasive bladder cancer (NM-MIBC)
37. A phase III randomised study of concomitant induction radiochemotherapy testing two modalities of radiosensitisation by cisplatin (standard versus daily) for limited small-cell lung cancer
38. A significant proportion of elderly patients develop hormone-dependant “luminal-B” tumours associated with aggressive characteristics
39. Caspofungin first-line therapy for invasive aspergillosis in allogeneic hematopoietic stem cell transplant patients: an European Organisation for Research and Treatment of Cancer study
40. The use of low-energy laser (LEL) for the prevention of chemotherapy- and/or radiotherapy-induced oral mucositis in cancer patients: results from two prospective studies
41. Acute confusion in patients with systemic cancer
42. Causes of fever in cancer patients (prospective study over 477 episodes)
43. A phase III randomised trial comparing sequential chemotherapy using cisplatin-based regimen and paclitaxel to cisplatin-based chemotherapy alone in advanced non-small-cell lung cancer
44. p-53 gene mutations as a predictive marker in a population of advanced breast cancer patients randomly treated with doxorubicin or docetaxel in the context of a phase III clinical trial
45. Low mannose-binding lectin concentration is associated with severe infection in patients with hematological cancer who are undergoing chemotherapy
46. Bacteraemia in febrile neutropenic cancer patients
47. 72TiP ROSALINE: A phase II, single-arm, neoadjuvant study of targeting ROS1 in combination with endocrine therapy (ET) in invAsive Lobular carcINoma of the brEast
48. Ki-67 expression and patients survival in lung cancer: systematic review of the literature with meta-analysis
49. A prospective randomised evaluation of G-CSF or G-CSF plus oral antibiotics in chemotherapy-treated patients at high risk of developing febrile neutropenia
50. HER-2/neu as a Predictive Marker in a Population of Advanced Breast Cancer Patients Randomly Treated Either with Single-agent Doxorubicin or Single-agent Docetaxel
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.